Alnylam Pharmaceuticals Ownership | Who Owns Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals Ownership Summary
Alnylam Pharmaceuticals is owned by 102.93% institutional investors, 3.80% insiders. Capital world investors is the largest institutional shareholder, holding 12.96% of ALNY shares. Capital Group Growth Fnd of Amer Comp is the top mutual fund, with 7.81% of its assets in Alnylam Pharmaceuticals shares.
ALNY Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Alnylam Pharmaceuticals | 102.93% | 3.80% | -6.73% |
Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Capital world investors | 16.81M | 12.96% | $5.48B |
Fmr | 13.49M | 10.49% | $3.17B |
Vanguard group | 12.73M | 9.90% | $3.00B |
Blackrock funding, inc. /de | 9.98M | 7.70% | $3.25B |
Blackrock | 9.55M | 7.57% | $2.32B |
Capital research global investors | 7.19M | 5.55% | $2.35B |
Regeneron pharmaceuticals | 4.44M | 3.43% | $1.45B |
T. rowe price investment management | 4.28M | 3.30% | $1.40B |
Wellington management group llp | 4.20M | 3.26% | $987.51M |
Baillie gifford | 4.04M | 3.14% | $950.71M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Regeneron pharmaceuticals | 4.44M | 97.59% | $1.45B |
Palo alto investors lp | 75.53K | 5.24% | $24.63M |
Bellevue group | 676.37K | 4.86% | $220.56M |
Eagle health investments lp | 76.26K | 4.40% | $17.94M |
Ikarian capital | 56.59K | 3.54% | $18.45M |
Parkman healthcare partners | 92.34K | 3.46% | $30.11M |
Orbis allan gray | 2.12M | 3.36% | $691.77M |
Orbimed advisors | 341.90K | 2.79% | $111.49M |
Rosenblum silverman sutton s f inc /ca | 34.39K | 2.72% | $11.21M |
Casdin capital | 81.50K | 2.42% | $26.58M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Norges bank | 2.46M | 0.08% | 2.46M |
Holocene advisors, lp | 596.82K | 0.47% | 596.82K |
Blackrock | 9.55M | 0.05% | 522.66K |
Orbis allan gray | 2.12M | 3.36% | 486.49K |
Blackrock funding, inc. /de | 9.98M | 0.06% | 420.78K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Capital investors | - | - | -1.42M |
Fmr | 13.49M | 0.19% | -1.19M |
Baillie gifford | 4.04M | 0.73% | -846.74K |
Wellington management group llp | 4.20M | 0.18% | -756.72K |
Logos global management lp | - | - | -500.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 2.46M | 0.08% | 2.46M | $577.94M |
Holocene advisors, lp | 596.82K | 0.47% | 596.82K | $194.62M |
Bank of america corp /de/ | 83.50K | 0.00% | 83.50K | $20.29M |
Kynam capital management, lp | 43.00K | 0.81% | 43.00K | $10.45M |
Fjarde ap-fonden (the fourth swedish national pensionfund) | 28.41K | 0.08% | 28.41K | $6.91M |
Sold Out
Holder | Change |
---|---|
Bear mountain capital | -1.00 |
Financial gravity asset management | -1.00 |
Johnson financial group | -1.00 |
Salem investment counselors | -1.00 |
Halbert hargrove global advisors | -1.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 685 | 2.09% | 133,478,551 | 3.70% | 102 | 1.04% | 354 | 1.14% | 220 | 10.00% |
Mar 31, 2025 | 28 | -95.52% | 1,770,848 | -98.63% | 1 | 0.01% | 11 | -96.63% | 10 | -94.71% |
Dec 31, 2024 | 603 | -0.33% | 129,230,860 | 5.02% | 100 | 1.10% | 315 | -2.78% | 183 | 6.40% |
Sep 30, 2024 | 599 | 4.17% | 123,006,457 | 2.58% | 95 | 1.07% | 320 | 10.73% | 170 | 4.94% |
Jun 30, 2024 | 571 | 3.25% | 119,905,127 | 6.57% | 95 | 1.19% | 286 | 4.38% | 162 | 3.18% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Capital Group Growth Fnd of Amer Comp | 10.18M | 7.81% | - |
American Funds Growth Fund of Amer A | 10.18M | 7.81% | - |
Vanguard US Total Market Shares ETF | 4.07M | 3.15% | 54.28K |
Vanguard Total Stock Mkt Idx Inv | 4.10M | 3.13% | -95.47K |
VA CollegeAmerica Amcap 529A | 3.73M | 2.89% | 658.62K |
Capital Group New Perspective Comp | 2.93M | 2.25% | - |
American Funds New Perspective A | 2.93M | 2.25% | - |
Vanguard Mid Cap Index Institutional | 2.91M | 2.22% | 31.33K |
Capital Group AMCAP Composite | 2.40M | 1.84% | - |
American Funds AMCAP A | 2.40M | 1.84% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 18, 2025 | Garg Pushkal | EVP Chief R&D | Sell | $46.55K |
Aug 18, 2025 | Garg Pushkal | EVP Chief R&D | Sell | $17.47K |
Aug 18, 2025 | Garg Pushkal | EVP Chief R&D | Sell | $40.49K |
Aug 18, 2025 | Garg Pushkal | EVP Chief R&D | Sell | $17.59K |
Aug 18, 2025 | Garg Pushkal | EVP Chief R&D | Sell | $149.02K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 58 |
2025 Q2 | - | 17 |
2025 Q1 | - | 152 |
2024 Q4 | - | 36 |
2024 Q3 | - | 16 |
ALNY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools